Patients with only NAFL carry a very low risk of adverse outcomes11, whereas the presence of NASH increases the risks of liver and possibly non-liver-related outcomes compared to those of patients with NAFL alone
Patient safety issues in the GLP-1 space this week Reddit, September 2, 2025 (Click the image to enlarge it) Although online searches turn up many businesses selling what they call GLP-1 drops for people who wish to avoid injections, there is no evidence that these products contain GLP-1s or that they would be effective if they did
Overman MJ, Kee BK, Fogelman DR, Eng C, Vilar Sanchez E, Shroff RT, Dasari A, Wolff RA, Morris J, Kopetz S
Understanding Semaglutide: What You Need to Know Semaglutide is a powerful GLP-1 receptor agonist specifically designed for adults grappling with obesity or combined with a weight-related condition
Semaglutide activates GLP-1 receptors in the hypothalamus (appetite), brainstem (fullness/nausea), pancreas (insulin), stomach (gastric emptying), and targets in the heart, liver, and kidneys
#nyee #mountsinai #weightlossdrugs #wegovy #obesitydrugs To view or add a comment, sign in More Relevant Posts Eli Lilly's investigational triple agonist retatrutide delivered A1c reductions of up to 2% and nearly 17% body weight loss in 40 weeks